Nab-paclitaxel Compared With Docetaxel Followed by Anthracyclines and Cyclophosphamide in the Neoadjuvant Breast Cancer
Clinical trial NCT04182568 · UNKNOWN
Trial details
- NCT number
- NCT04182568
- Sponsor
- Xijing Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-21
- Primary completion
- 2021-08-21
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.